Fusionbio, Inc

Global Vaccines Inc. is a not-for-profit organization based in Chapel Hill, North Carolina, dedicated to developing vaccines for diseases prevalent in developing countries, including HIV/AIDS, polio, dengue fever, malaria, and rotavirus. Founded in 2002, the company focuses on research and development, leveraging core capabilities in tissue culture and tissue engineering. With a commitment to addressing immunologic and inflammatory diseases, as well as biodefense and infectious diseases, Global Vaccines Inc. is actively working on innovative solutions, including novel adjuvants and new live attenuated virus vaccines. The organization plays a vital role in the life sciences ecosystem of North Carolina, contributing to the advancement of public health initiatives. Generated from the website

Clarus Biologics, Inc., located in Chapel Hill, NC, is dedicated to enhancing the availability of safe and effective prophylactic and therapeutic technologies. The company's mission focuses on developing innovative solutions to improve health outcomes. With a commitment to advancing medical technologies, Clarus Biologics aims to meet the growing demands for healthcare solutions. Their efforts are directed towards providing impactful products that contribute to better patient care and treatment options. Generated from the website

Biogen Idec Inc is a leading biotechnology company based in Durham, NC, specializing in the development of transformative medicines for a range of diseases, including Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Postpartum Depression, Lupus, Multiple Sclerosis, Spinal Muscular Atrophy, and Friedreich Ataxia. With a strong focus on science and innovation, Biogen is dedicated to improving patient lives and solving societal problems through its diverse and passionate team of professionals. Driven by a deep sense of care and a commitment to making a difference, Biogen pioneers groundbreaking research and clinical trials, aiming to transform the lives of patients worldwide. With a strong emphasis on access and health equity, as well as diversity and inclusion, Biogen is at the forefront of developing medicines that have the potential to change the course of debilitating diseases. Through its relentless pursuit of scientific advancements, Biogen continues to inspire and create new possibilities in the field of biotechnology.Generated from the website